NinePointTwo Capital’s Evolus EOLS Stock Holding History

NinePointTwo Capital’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,136	Closed	-$326K	–	233
2021 Q4	$326K	Buy	50,136 +37,996	+313%	+$261K	0.11%	44
2021 Q3	$92K	Buy	+12,140	New	+$126K	0.04%	73

Other funds holding EOLS

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NinePointTwo Capital's EOLS Position: Q1 2022 in Review

NinePointTwo Capital sold out of Evolus (EOLS) in Q1 2022, closing a stake of 50,136 shares — an estimated $326K sold.

NinePointTwo Capital first reported a position in EOLS in Q3 2021 and held it in 2 quarters. The position peaked at $326K in Q4 2021. 118 funds tracked by Wall St. Rank hold EOLS as of Q1 2022.

NinePointTwo Capital reported no remaining Evolus position as of Q1 2022 after selling out during the quarter.
NinePointTwo Capital sold 50,136 Evolus shares in Q1 2022, an estimated $326K.
NinePointTwo Capital first reported a position in Evolus in Q3 2021 and held it in 2 quarters.
NinePointTwo Capital's Evolus position peaked at $326K in Q4 2021.
118 funds tracked by Wall St. Rank held Evolus as of Q1 2022.

Based on NinePointTwo Capital's 13F filing for Q1 2022, filed 16 May 2022.